NCT01257568

Rejuvenate Modular Outcomes Study

A Prospective, Post-market, Multi-center Study of the Outcomes of the Rejuvenate® Modular Hip System

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 42 (actual)
• Sponsor: Stryker Orthopaedics · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will be an evaluation of the Rejuvenate® Modular Hip System for primary total hip replacement (THR) with a cementless application in a consecutive series of patients who meet the eligibility criteria. Subjects will be evaluated for freedom of hip revision at 5 years and clinical outcomes for up to 10 years after surgery.

Conditions

• Arthroplasty, Replacement, Hip

Interventions

Type	Name	Description
DEVICE	Rejuvenate Modular Hip	Rejuvenate Modular Hip

Timeline

• Start date: 2010-11-01
• Primary completion: 2017-06-06
• Completion: 2022-01-20
• First posted: 2010-12-09
• Last updated: 2022-02-16
• Results posted: 2019-01-24

Locations

3 sites across 1 country: United States